Table 2 pre-and perinatal data
BPD n = 9 | No-BPD n = 13 | CONTROL n = 15 | |
|---|---|---|---|
Gestational age (weeks) | 26.6 ± 1.6 (24.6–29.7) | 29.1 ± 1.8 (25.0–31.0) | 39.3 ± 0.9 (38.0–41.0) |
Birthweight (g) | 766.7 ± 212.4 (450–1080) | 117.3 ± 242.6 (780–1440) | 3382.7 ± 327.5 (2800–3950) |
SGA (number of total/percent) | 3/9 (33%) | 3/13 (23%) | 3/15 (20%) |
Antenatal steroids (number of total/percent) | 5/9 (56%) | 7/13 (54%) | 0 |
Surfactant (number of total/percent) | 8/9 (89%) | 4/13 (31%) | 0 |
Respiratory support | |||
Synchronized-intermittent-mandatory ventilation (SIMV) Number of patients/days | 9/9 24.9 ± 14.4 (2–47) | 8/13 3.7 ± 5.3 (0–19) | 0/15 |
High-frequency ventilation | 4/9 3.4 ± 5.0 (0–12) | 0/13 | 0/15 |
Binasal continuous-positive-pressure ventilation (CPAP) | 27.8 ± 9.5 (14–40) | 7.1 ± 5.1 (0–20) | 0/15 |